Drug: Esketamine: chronic pain clinical trials
Registry records that list "Drug: Esketamine" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes NCT06087510 | Recruiting | Phase 4 | China | Peking University First Hospital | 2024-01-24 |
| Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery NCT06920576 | Active, not recruiting | Phase 1, Phase 2 | China | The Second People's Hospital of Huai'an | 2025-03-01 |
| Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery NCT06062550 | Active, not recruiting | Phase 4 | China | Peking University First Hospital | 2023-10-24 |
| Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes NCT05718544 | Completed | Phase 4 | China | Peking University First Hospital | 2023-01-30 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.